Integrated Wealth Concepts LLC Trims Stake in The Clorox Company (NYSE:CLX)

Integrated Wealth Concepts LLC trimmed its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 30.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,415 shares of the company's stock after selling 4,061 shares during the period. Integrated Wealth Concepts LLC's holdings in Clorox were worth $1,534,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Mizuho Securities USA LLC lifted its stake in Clorox by 46,877.8% in the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company's stock valued at $733,095,000 after buying an additional 4,490,421 shares in the last quarter. Nuance Investments LLC lifted its position in shares of Clorox by 150.6% in the second quarter. Nuance Investments LLC now owns 1,597,674 shares of the company's stock valued at $218,035,000 after acquiring an additional 960,094 shares in the last quarter. Van ECK Associates Corp boosted its stake in shares of Clorox by 2.2% in the third quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company's stock worth $237,372,000 after acquiring an additional 31,510 shares during the last quarter. Bank of New York Mellon Corp increased its position in shares of Clorox by 14.4% during the second quarter. Bank of New York Mellon Corp now owns 961,387 shares of the company's stock worth $131,200,000 after purchasing an additional 120,716 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in Clorox by 11.9% in the 2nd quarter. Dimensional Fund Advisors LP now owns 802,237 shares of the company's stock valued at $109,483,000 after purchasing an additional 85,529 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on CLX shares. BNP Paribas upgraded shares of Clorox to a "strong sell" rating in a research report on Friday, September 6th. DA Davidson raised their target price on shares of Clorox from $153.00 to $171.00 and gave the stock a "neutral" rating in a research note on Monday, November 4th. Barclays upped their price target on Clorox from $137.00 to $139.00 and gave the company an "underweight" rating in a research report on Friday, November 1st. Evercore ISI reduced their price objective on Clorox from $140.00 to $139.00 and set an "underperform" rating on the stock in a research report on Monday, October 14th. Finally, Citigroup raised their target price on Clorox from $165.00 to $170.00 and gave the stock a "neutral" rating in a research note on Friday, September 6th. Five equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $155.00.

Clorox Trading Down 1.6 %

Clorox stock traded down $2.77 during midday trading on Friday, reaching $166.97. 1,217,064 shares of the stock traded hands, compared to its average volume of 1,054,507. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The firm has a market cap of $20.67 billion, a PE ratio of 58.18, a price-to-earnings-growth ratio of 3.10 and a beta of 0.42. The company has a 50-day simple moving average of $163.50 and a two-hundred day simple moving average of $150.61. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping the consensus estimate of $1.36 by $0.50. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company's quarterly revenue was up 27.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.49 earnings per share. Research analysts expect that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be issued a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 annualized dividend and a yield of 2.92%. Clorox's dividend payout ratio (DPR) is 170.03%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.